CP and rheumatoid arthritis: Combining plasma CP, the bone resorption biomarker, hydroxyproline (hyp) and anti-CCP antibody status in a 4-group classifier algorithm (classifying good skeletal health, eOA, eRA and non-RA) provided for diagnosis of both presence and type of early-stage arthritis, giving moderate evidence for the presence of eOA and eRA [11].